Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Functional assessment of HDL: Moving beyond static measures for risk assessment.

× No keyword cloud information.

8 in total

1. Systemic inflammation and the dynamics of HDL cholesterol-associated residual cardiovascular risk.

Authors: Robert S Rosenson
Journal: Curr Atheroscler Rep Date: 2011-06 Impact factor: 5.113

2. In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.

Authors: Demidmaa Tuvdendorj; Alejandro O Munoz; Viviana Ruiz-Barros; Jean-Marc Schwarz; Giuseppe Montalto; Manisha Chandalia; Lawrence C Sowers; Manfredi Rizzo; Elizabeth J Murphy; Nicola Abate
Journal: Atherosclerosis Date: 2016-06-13 Impact factor: 5.162

Review 3. New technologies personalize diagnostics and therapeutics.

Authors: Robert S Rosenson
Journal: Curr Atheroscler Rep Date: 2010-05 Impact factor: 5.113

Review 4. Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors: Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal: Br J Pharmacol Date: 2017-03-23 Impact factor: 8.739

5. Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction.

Authors: Aleksander Siniarski; Rafal Grzybczak; Pawel Rostoff; Jaroslaw Zalewski; Urszula Czubek; Jadwiga Nessler; Grzegorz Gajos
Journal: Anatol J Cardiol Date: 2018-06 Impact factor: 1.596

Functional assessment of HDL: Moving beyond static measures for risk assessment.

1. Systemic inflammation and the dynamics of HDL cholesterol-associated residual cardiovascular risk.

2. In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.

Review 3. New technologies personalize diagnostics and therapeutics.

Review 4. Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

5. Association of serum levels of lipoprotein A-I and lipoprotein A-I/A-II with high on-treatment platelet reactivity in patients with ST-segment elevation myocardial infarction.

6. High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes.

7. Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population.

Review 8. High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.